Content
05/13/2025
Boston, MA USA
Somite Therapeutics
completed $47 million Series A Round funding. Investors include
Khosla Ventures (lead), Ajinomoto Group Ventures, SciFi VC, Chan Zuckerberg Initiative, Fusion Fund, Pitango Venture Capital, TechAviv Founders Fund, Harpoon Ventures.
About
Somite.ai is a venture-backed company aiming to become the OpenAI of stem cell biology, developing AI foundation models to produce human tissue for cell therapies at scale for diseases such as diabetes, obesity, and muscular dystrophies. Somite's AI platform, AlphaStem, fuels a virtuous cycle: It enables new cell therapies, generating massive data that further improve the platform, empowering even faster therapy creation with broader applications.
Startup
Sector:
AI
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
